Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.3 USD | -0.22% |
|
-1.11% | -24.39% |
01/07 | RBC Lowers Price Target on Illumina to $242 From $249, Keeps Outperform Rating | MT |
01/07 | ANALYST RECOMMENDATIONS : Nvidia, Broadcom, Progressive, Draftkings, Moody's... | ![]() |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.39% | 16.77B | |
+0.91% | 204B | |
+3.74% | 178B | |
+28.89% | 154B | |
+31.66% | 112B | |
+1.37% | 64.16B | |
+19.45% | 54.88B | |
-2.27% | 46.69B | |
-9.28% | 36.8B | |
-0.10% | 35.26B |
- Stock Market
- Equities
- ILMN Stock
- News Illumina, Inc.
- Transcript : Illumina, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 11